1. Home
  2. List
Reference Patent

Reference - List

When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 68 Hits
  • Search Condition : Filter (MeSH = Liver Neoplasms / metabolism*)
Species Resource
Human and Animal Cells HuH-6(RCB1367) Characterization of HuH6, Hep3B, HepG2 and HLE liver cancer cell lines by WNT/β - catenin pathway, microRNA expression and protein expression profile.
Human and Animal Cells LoVo(RCB1639) , CW-2(RCB0778) Analysis of tissue factor and tissue factor pathway inhibitor expression in human colorectal carcinoma cell lines and metastatic sublines to the liver.
Human and Animal Cells Li-7(RCB1941) A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7.
Human and Animal Cells Huh7, Hep G2(RCB1886) Vasoactive intestinal peptide increases apoptosis of hepatocellular carcinoma by inhibiting the cAMP/Bcl-xL pathway.
Human and Animal Cells Huh7 TCF12 promotes the tumorigenesis and metastasis of hepatocellular carcinoma via upregulation of CXCR4 expression.
Human and Animal Cells HuH7 Forced expression of DYRK2 exerts anti-tumor effects via apoptotic induction in liver cancer.
Human and Animal Cells Hep G2, HuH-7 Hepatic Stellate Cells Contribute to the Tumor Malignancy of Hepatocellular Carcinoma Through the IL-6 Pathway.
DNA material CSII-CMV-MCS-IRES2-Bsd (RDB04385) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
Human and Animal Cells Huh7 Pigment epithelium-derived factor promotes tumor metastasis through an interaction with laminin receptor in hepatocellular carcinomas.
Human and Animal Cells HuH-7 Downregulation of Nedd4L predicts poor prognosis, promotes tumor growth and inhibits MAPK/ERK signal pathway in hepatocellular carcinoma.
Human and Animal Cells HuH-6(RCB1367) Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation.
Human and Animal Cells Hep G2(RCB1886) Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake.
Human and Animal Cells PLC/PRF/5(ECA85061113) Clinical Significance of FANCD2 Gene Expression and its Association with Tumor Progression in Hepatocellular Carcinoma.
Human and Animal Cells HuH-7(RCB1366) Id4 promotes cell proliferation in hepatocellular carcinoma.
Human and Animal Cells SSP-25(RCB1293) Apical membrane expression of distinct sulfated glycans represents a novel marker of cholangiolocellular carcinoma.
Human and Animal Cells HuCCT1(RCB1960) Induction of MITF expression in human cholangiocarcinoma cells and hepatocellular carcinoma cells by cyclopamine, an inhibitor of the Hedgehog signaling.
DNA material CSII-EF-MCS (RDB04378). Fatty Acid Binding Protein 4 (FABP4) Overexpression in Intratumoral Hepatic Stellate Cells within Hepatocellular Carcinoma with Metabolic Risk Factors.
Human and Animal Cells Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
Human and Animal Cells MYC activates stem-like cell potential in hepatocarcinoma by a p53-dependent mechanism.
Human and Animal Cells Efficient induction of apoptosis by wee1 kinase inhibition in hepatocellular carcinoma cells.